Kolexia
Saint Redoules Angélique Oncologie médicale
Saint Redoules Angélique
Oncologie médicale
Hp A. Tzanck Mougins Sophia Antipolis
Mougins, France
59 Activités
323 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome épidermoïde Tumeurs de l'anus Tumeurs colorectales Tumeurs du pancréas Carcinome épidermoïde de la tête et du cou Tumeurs de la tête et du cou Adénocarcinome Infections à papillomavirus

Collaborateurs

Voir plus
Evesque Ludovic
Evesque Ludovic
Centre Antoine Lacassagne, Nice, France
Francois Eric
Francois Eric
Centre Antoine Lacassagne, Nice, France
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Ouvrier Delphine
Ouvrier Delphine
Hôpital De l'Archet, Nice, France

Industries

Voir plus
Advanced Accelerator Applications
9 collaboration(s)
Dernière en 2023
Servier
7 collaboration(s)
Dernière en 2023
Merck-Serono
5 collaboration(s)
Dernière en 2023
Amgen
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
British journal of cancer   06 janvier 2024
651P DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: A multicenter propensity score matching study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.
Experimental hematology & oncology   21 juillet 2023
Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection: A Sequential Window of Opportunity Trial of Anti-PD-L1/TGF-beta Trap (M7824 ) Alone and in Combination With TriAd Vaccine, and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection.
Essai Clinique (National Cancer Institute)   19 juillet 2023
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
Journal of gastrointestinal oncology   10 avril 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   21 février 2023
Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer: Phase I/II Study of M7824 Plus Curative Intent Re-Irradiation With Stereotactic Body Radiation Therapy (SBRT) in Patients With Local-Regionally Recurrent Head and Neck Squamous Cell Carcinoma
Essai Clinique (M.D. Anderson Cancer Center)   27 octobre 2022
429P Management of localized anal cancer and prognostic factors in the elderly: Results of the French multicenter cohort FFCD – ANABASE
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
International journal of cancer   14 juillet 2022
ICING: A Phase II Trial Assessing Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in a Pre-operative Setting for Resectable and Untreated Head and Neck Squamous Cell Carcinoma
Essai Clinique (Merck KGaA)   28 mars 2022